Vincent Le Moing - JoVE Visualize

Showing results (41-50 of 115) with videos related to

Pageof 12

Sort By:

Journal of Acquired Immune Deficiency Syndromes (1999)|May 29, 2009

Uncontrolled viral replication as a risk factor for non-AIDS severe clinical events in HIV-infected patients on long-term antiretroviral therapy: APROCO/COPILOTE (ANRS CO8) cohort studyTristan Ferry, François Raffi, Fidéline Collin-Filleul, et al.

BMJ Open|November 27, 2012

Impact of immunodepression and moderate alcohol consumption on coronary and other arterial disease events in an 11-year cohort of HIV-infected patients on antiretroviral therapyMaria Patrizia Carrieri, Camelia Protopopescu, Vincent Le Moing, et al.

Journal of Acquired Immune Deficiency Syndromes (1999)|March 1, 2005

T-Cell surface CCR5 density is not correlated with hepatitis severity in hepatitis C virus/HIV-coinfected individuals: implications for the therapeutic use of CCR5 antagonistsThierry Vincent, Pierre Portales, Vincent Baillat, et al.

The Journal of Antimicrobial Chemotherapy|September 16, 2016

Failure to achieve immunological recovery in HIV-infected patients with clinical and virological success after 10 years of combined ART: role of treatment courseFrançois Raffi, Vincent Le Moing, Alex Assuied, et al.

Data in Brief|November 23, 2020

Data on prognostic factors associated with 3-month and 1-year mortality from infective endocarditisMagali Collonnaz, Marie-Line Erpelding, François Alla, et al.

Annals of Epidemiology|September 20, 2020

Impact of referral bias on prognostic studies outcomes: insights from a population-based cohort study on infective endocarditisMagali Collonnaz, Marie-Line Erpelding, François Alla, et al.

European Heart Journal|October 17, 2006

Diabetes mellitus and infective endocarditis: the insulin factor in patient morbidity and mortalityXavier Duval, François Alla, Thanh Doco-Lecompte, et al.

European Heart Journal|February 12, 2009

The impact of valve surgery on short- and long-term mortality in left-sided infective endocarditis: do differences in methodological approaches explain previous conflicting results?Aurélie Bannay, Bruno Hoen, Xavier Duval, et al.

Journal of Acquired Immune Deficiency Syndromes (1999)|December 6, 2003

Plasma levels of indinavir and nelfinavir at time of virologic response may have a different impact on the risk of further virologic failure in HIV-infected patientsVincent Le Moing, Gilles Peytavin, Valérie Journot, et al.

Infectious Diseases Now|February 10, 2025

Real-world use, effectiveness, and safety of ceftazidime-avibactam: Results of the French cohort OZAVIELionel Piroth, Virginie Vitrat, Vincent Le Moing, et al.

Pageof 12

Showing results (41-50 of 115) with videos related to

Sort By:

Pageof 12

Journal of Acquired Immune Deficiency Syndromes (1999)|May 29, 2009

Uncontrolled viral replication as a risk factor for non-AIDS severe clinical events in HIV-infected patients on long-term antiretroviral therapy: APROCO/COPILOTE (ANRS CO8) cohort studyTristan Ferry, François Raffi, Fidéline Collin-Filleul, et al.

BMJ Open|November 27, 2012

Impact of immunodepression and moderate alcohol consumption on coronary and other arterial disease events in an 11-year cohort of HIV-infected patients on antiretroviral therapyMaria Patrizia Carrieri, Camelia Protopopescu, Vincent Le Moing, et al.

Journal of Acquired Immune Deficiency Syndromes (1999)|March 1, 2005

T-Cell surface CCR5 density is not correlated with hepatitis severity in hepatitis C virus/HIV-coinfected individuals: implications for the therapeutic use of CCR5 antagonistsThierry Vincent, Pierre Portales, Vincent Baillat, et al.

The Journal of Antimicrobial Chemotherapy|September 16, 2016

Failure to achieve immunological recovery in HIV-infected patients with clinical and virological success after 10 years of combined ART: role of treatment courseFrançois Raffi, Vincent Le Moing, Alex Assuied, et al.

Data in Brief|November 23, 2020

Data on prognostic factors associated with 3-month and 1-year mortality from infective endocarditisMagali Collonnaz, Marie-Line Erpelding, François Alla, et al.

Annals of Epidemiology|September 20, 2020

Impact of referral bias on prognostic studies outcomes: insights from a population-based cohort study on infective endocarditisMagali Collonnaz, Marie-Line Erpelding, François Alla, et al.

European Heart Journal|October 17, 2006

Diabetes mellitus and infective endocarditis: the insulin factor in patient morbidity and mortalityXavier Duval, François Alla, Thanh Doco-Lecompte, et al.

European Heart Journal|February 12, 2009

The impact of valve surgery on short- and long-term mortality in left-sided infective endocarditis: do differences in methodological approaches explain previous conflicting results?Aurélie Bannay, Bruno Hoen, Xavier Duval, et al.

Journal of Acquired Immune Deficiency Syndromes (1999)|December 6, 2003

Plasma levels of indinavir and nelfinavir at time of virologic response may have a different impact on the risk of further virologic failure in HIV-infected patientsVincent Le Moing, Gilles Peytavin, Valérie Journot, et al.

Infectious Diseases Now|February 10, 2025

Real-world use, effectiveness, and safety of ceftazidime-avibactam: Results of the French cohort OZAVIELionel Piroth, Virginie Vitrat, Vincent Le Moing, et al.

Pageof 12